Literature DB >> 9220271

Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.

A Tanabe1, M Naruse, K Naruse, M Hase, T Yoshimoto, M Tanaka, T Seki, R Demura, H Demura.   

Abstract

We determined functional and morphological changes of the heart by 2-dimensional and pulse Doppler echocardiography in 20 patients with primary aldosteronism and compared the results with those in 50 healthy normotensive subjects, 12 patients with Cushing's syndrome, 9 patients with pheochromocytoma, and 47 patients with essential hypertension. All hypertensive groups had greater left ventricular mass indexes than did the normotensive group (76.9 +/- 17.2 g/m2). Despite similar age distribution, blood pressure during antihypertensive treatment, and duration of hypertension, the primary aldosteronism group had a significantly greater left ventricular mass index (152.5 +/- 42.5 g/m2) than did the Cushing's syndrome (103.4 +/- 37.5 g/m2), pheochromocytoma (122.4 +/- 28.5 g/m2), and essential hypertension (101.4 +/- 32.8 g/m2) groups. The left ventricular posterior wall thickness and interventricular septal wall thickness were significantly greater in the hypertensive groups than in the normotensive group and also significantly greater in the primary aldosteronism group than in any of the other hypertensive groups. By contrast, there were no significant differences among the four hypertensive groups in any variable of systolic or diastolic function of the heart. The results suggest that left ventricular hypertrophy is more pronounced in patients with primary aldosteronism than in patients with other forms of hypertension. It is therefore important to echocardiographically evaluate cardiac hypertrophy as a risk factor of morbidity and mortality in patients with this low renin hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220271     DOI: 10.1291/hypres.20.85

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  25 in total

Review 1.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

2.  Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment.

Authors:  Guido Zavatta; Guido Di Dalmazi; Carmine Pizzi; Giovanni Bracchetti; Cristina Mosconi; Caterina Balacchi; Uberto Pagotto; Valentina Vicennati
Journal:  Endocrine       Date:  2018-11-14       Impact factor: 3.633

3.  Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Vittoria Rufini; Giorgio Treglia; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2007-01-23       Impact factor: 3.445

Review 4.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

5.  Central mineralocorticoid receptors and cardiovascular disease.

Authors:  Elise P Gomez Sanchez
Journal:  Neuroendocrinology       Date:  2009-07-07       Impact factor: 4.914

Review 6.  Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.

Authors:  Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2014-12       Impact factor: 2.668

7.  Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.

Authors:  Elise P Gomez-Sanchez; Damian G Romero; Angela F de Rodriguez; Mary P Warden; Zygmunt Krozowski; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2007-11-26       Impact factor: 4.736

Review 8.  Management of hypertension in primary aldosteronism.

Authors:  Anna Aronova; Thomas J Fahey; Rasa Zarnegar
Journal:  World J Cardiol       Date:  2014-05-26

9.  Relations of biomarkers representing distinct biological pathways to left ventricular geometry.

Authors:  Raghava S Velagaleti; Philimon Gona; Daniel Levy; Jayashri Aragam; Martin G Larson; Geoffrey H Tofler; Wolfgang Lieb; Thomas J Wang; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

Review 10.  Aldosterone--a hormone of cardiovascular adaptation and maladaptation.

Authors:  Theodore L Goodfriend
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.